ICH E8(R1) General Considerations for Clinical Studies

This revised guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) describes internationally accepted principles and practices in the design and conduct of clinical studies of drug and biological products. The guidance incorporates the most current concepts achieving fit-for-purpose data quality as one of the essential considerations for all clinical trials.

Download the full guidance here

Previous
Previous

FDA Responses to Good Clinical Practice Inquiries

Next
Next

Conduct of Clinical Trials During the COVID-19 Public Health Emergency